Burkhardt, Ute EWu, Catherine2014-03-112013Burkhardt, Ute E., and Catherine J Wu. 2013. “Boosting leukemia-specific T cell responses in patients following stem cell transplantation.” Oncoimmunology 2 (11): e26587. doi:10.4161/onci.26587. http://dx.doi.org/10.4161/onci.26587.2162-4011http://nrs.harvard.edu/urn-3:HUL.InstRepos:11879631Whole tumor cell-based vaccines administered within the first 2 to 3 months after allogeneic stem cell transplantation stand out as a promising approach to enhance graft-vs.-leukemia responses. Herein, the implications of this finding for the development of strategies to improve the outcome of patients subjected to allogeneic stem cell transplantation are discussed.en-UScancer vaccinesCLLimmune reconstitutionmultiepitope vaccinesneoantigensstem cell transplantationwhole tumor-cell vaccinationJournal Article2014-03-1110.4161/onci.26587